Have Questions? Email support@soracilabs.com
TB-500 and Thymosin β4: The Fragment Is Not the Protein
Thymosin beta-4 is a 43-residue actin-sequestering protein. TB-500, as characterised analytically, is a seven-residue fragment of it. What that difference means for research.
TB-500 is one of the most widely sold research peptides and one of the most widely misdescribed. The confusion is not about what it does — it is about what it is. Thymosin beta 4 (thymosin β4) is a 43-residue protein. TB-500, as characterised in the analytical literature, is a seven-residue fragment of it. Those are not the same molecule, and the distinction matters for anyone designing an experiment around either one.
The short version
- Thymosin β4 (Tβ4) is a 43-amino-acid intracellular protein and the principal G-actin sequestering molecule in mammalian cells.
- Its actin-binding activity localises to a short motif, LKKTETQ, at residues 17–23.
- TB-500 products have been characterised analytically as the N-terminally acetylated 17–23 fragment — that motif alone, not the full protein.
- The full protein has documented activities beyond actin binding, including integrin-linked kinase activation, that a seven-residue fragment should not be assumed to reproduce.
What thymosin β4 actually does
Actin exists in two states: monomeric G-actin, free in the cytosol, and filamentous F-actin, polymerised into the cytoskeleton. A cell that needs to change shape, migrate, or heal a wound needs a large, rapidly mobilisable pool of G-actin held in reserve — and it needs that pool kept out of spontaneous polymerisation until it is called on.
Thymosin β4 is the molecule that does the holding. It is the main G-actin sequestering protein in mammalian cells, present at high intracellular concentration, and it binds actin monomers in a 1:1 complex that keeps them polymerisation-competent but inactive. When the cell signals for filament assembly, that reserve becomes available.
That single function sits underneath most of what the Tβ4 literature reports. Cell migration, angiogenesis, corneal and dermal wound repair, and tissue remodelling all depend on rapid, directional cytoskeletal reorganisation, and all of them are downstream of the actin pool being available where and when it is needed.
TB-500: the thymosin β4 motif and the fragment
The actin-binding activity of Tβ4 does not require the whole 43-residue chain. It maps to a short hexapeptide/heptapeptide motif — LKKTETQ — at residues 17–23. This is the structural basis for the entire “short-form” approach: if the binding motif is what matters, synthesise the motif.
That is what TB-500 is. Analytical work characterising commercial TB-500 material identified it as the N-terminal acetylated 17–23 fragment of thymosin β4 — Ac-LKKTETQ. Acetylation of the N-terminus is a standard stabilisation step, the same logic as the Pro-Gly-Pro tail used in other peptide families.
Why this matters for your experiment
If a supplier lists “TB-500 (Thymosin β4)” you cannot infer molecular weight, purity specification, or expected activity from the name alone. A 43-residue protein of roughly 4.9 kDa and a seven-residue acetylated fragment of under 1 kDa behave differently in solution, run differently on HPLC, and are quantified differently on a molar basis. Check the certificate of analysis for the actual mass, not the product name.
Where the full protein does more than the motif
The most-cited mechanistic paper on Tβ4 is not about actin at all. Bock-Marquette and colleagues reported in Nature in 2004 that thymosin β4 activates integrin-linked kinase, promoting cardiac cell migration and survival in a myocardial injury model. ILK activation sits upstream of Akt signalling and is a distinct pathway from monomer sequestration.
Subsequent work extended the cardioprotection literature considerably, and separate programmes pursued Tβ4 in ophthalmology, where a topical formulation was developed for corneal epithelial repair.
The honest position on the fragment is this: the actin-sequestering function is motif-localised and reasonably expected to survive truncation; activities that depend on other regions of the protein, or on protein–protein interfaces larger than seven residues, are not. Published work on the full-length protein should not be cited as though it characterises the fragment.
Thymosin β4 full protein versus the TB-500 fragment
| Thymosin β4 (full length) | TB-500 (as characterised) | |
|---|---|---|
| Length | 43 amino acids | 7 amino acids |
| Approx. mass | ~4.9 kDa | <1 kDa |
| Sequence basis | Native human Tβ4 | Ac-LKKTETQ — residues 17–23, N-acetylated |
| Actin sequestration | Yes — principal G-actin binding protein | Motif retained |
| ILK / Akt signalling | Reported for full-length protein | Not established for the fragment |
| Typical research framing | Cell migration, angiogenesis, cardiac and corneal repair | Motif-level actin studies; tissue repair models |
Handling and reconstitution
- Supplied lyophilised. Store at −20 °C, protected from light, until reconstituted.
- Reconstitute with bacteriostatic water where a vial will be entered more than once.
- Add diluent slowly down the vial wall. Swirl to dissolve — do not shake or vortex.
- Both forms are highly water-soluble; a cloudy or incompletely dissolving solution warrants a second look at the material rather than more agitation.
- Date the vial at reconstitution, aliquot once, and avoid freeze–thaw cycling.
Full method in the peptide reconstitution guide. For the rationale behind pairing TB-500 with BPC-157, see our BPC-157 research guide.
TB-500 and thymosin beta 4: frequently asked questions
Is TB-500 the same as thymosin beta-4?
Not as the term is normally used. Analytical characterisation of commercial TB-500 identified it as the N-acetylated 17–23 fragment of Tβ4, a seven-residue peptide rather than the 43-residue protein.
What does “G-actin sequestering” mean?
It means holding actin monomers in a soluble, non-polymerised reserve so the cell can assemble filaments quickly when signalled, rather than relying on new synthesis.
Why is the fragment acetylated?
N-terminal acetylation removes a free amine that aminopeptidases recognise, which slows degradation. It is a stability modification, not a functional one.
Can full-length thymosin beta-4 research be applied to TB-500?
Only for the actin-binding function that the motif carries. Findings that depend on other regions of the protein — the integrin-linked kinase work, for instance — should not be assumed to transfer.
How do I tell which one I actually have?
Molecular weight on the certificate of analysis. Roughly 4.9 kDa indicates full-length protein; under 1 kDa indicates the fragment.
Related products
TB-500 10mgLyophilised thymosin β4 fragment. Research use only.View product →BPC-157 10mgGastric pentadecapeptide, frequently studied alongside TB-500.View product →Wolverine Blend (BPC-157 + TB-500) 10mgCombined preparation of both peptides.View product →Hospira Bacteriostatic Water 30mlPreserved diluent for multi-withdrawal vials.View product →
References
The primary literature below is indexed on PubMed, and compound records are held at PubChem.
- Bock-Marquette I, et al. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 2004. PMID 15565145.
- Synthesis and characterization of the N-terminal acetylated 17–23 fragment of thymosin β4 identified in TB-500. Analytical characterisation of commercial TB-500 material.
- Hinkel R, et al. Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection. Annals of the New York Academy of Sciences, 2012.
- Srivastava D, et al. Thymosin β4 is cardioprotective after myocardial infarction. Annals of the New York Academy of Sciences, 2007.
Research use only. All products sold by Soraci Labs are intended strictly for in-vitro laboratory research and are not for human or veterinary use, ingestion, injection, or any form of clinical application. Nothing on this page is medical advice or a claim of therapeutic benefit. This article summarises published preclinical literature for educational purposes only.
[…] fragment distinction trips people up regularly, which is why it has its own guide. For BPC-157 specifically, the research guide covers what the literature actually studies and how […]